T Acceleration Consortium News Today : Breaking News, Live Updates & Top Stories | Vimarsana

In less than a month, researchers have used AlphaFold, an artificial intelligence (AI)-powered protein structure database, to design and synthesize a potential drug to treat hepatocellular carcinoma (HCC), the most common type of primary liver cancer.

With the goal of accelerating scientific research through the application of artificial intelligence, Schmidt Futures is investing $148-million in nine global universities, including the University of Toronto.